Pulse nav.journalClub 활발한 토론 트렌드 탐색 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

© Synapse Social LLC, 2026

개인정보 처리방침

The End of B/Yamagata Influenza Transmission — Transitioning from Quadrivalent Vaccines | Synapse

February 28, 2024

B/Yamagata 인플루엔자 전파의 종말 — 4가 백신에서 3가 백신으로의 전환

Key Points

Key points are not available for this paper at this time.

Abstract

야마가타 혈통의 B형 인플루엔자가 2020년 초 이후로 유행하지 않았기 때문에, 전문가들은 4가 인플루엔자 백신을 사용하는 국가들이 3가 백신으로 돌아가야 한다고 동의하고 있다.

AI에게 질문

Like

Bookmark

Share

Cite This Study

Monto 외 (수요일), 이 질문을 연구하였다.

synapsesocial.com/papers/68e770a2b6db6435876e670c https://doi.org/https://doi.org/10.1056/nejmp2314801

AI에게 질문

Like

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions2022 · 30 citations
2Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?2022 · 116 citations
3Cocirculation of two distinct evolutionary lineages of influenza type B virus since 19831990 · 542 citations
4Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season.2014 · 151 citations
5Reappearance and Global Spread of Variants of Influenza B/Victoria/2/87 Lineage Viruses in the 2000–2001 and 2001–2002 Seasons2002 · 177 citations